iRhythm Holdings, Inc. (IRTC)

Market Cap	4.90B +39.8%
Revenue (ttm)	702.57M +25.5%
Net Income	-51.46M
EPS	-1.62
Shares Out	32.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	306,849
Open	152.22
Previous Close	152.22
Day's Range	146.89 - 152.35
52-Week Range	92.52 - 212.00
Beta	1.07
Analysts	Strong Buy
Price Target	217.31 (+42.86%)
Earnings Date	Feb 19, 2026

About IRTC

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 20, 2016
• Employees: 2,000
• Stock Exchange: NASDAQ
• Ticker Symbol: IRTC
• Website: https://www.irhythmtech.com

Financial Performance

In 2024, iRhythm Holdings's revenue was $591.84 million, an increase of 20.13% compared to the previous year's $492.68 million. Losses were -$113.29 million, -8.20% less than in 2023.

Analyst Summary

According to 13 analysts, the average rating for IRTC stock is "Strong Buy." The 12-month stock price target is $217.31, which is an increase of 42.86% from the latest price.

Price Target

$217.31

(42.86% upside)

Analyst Consensus: Strong Buy